Clinical features, treatment and outcomes of pembrolizumab induced autoimmune hemolytic anemia
Fields of Study & Subjects
Blood groups and transfusion
Erythrocyte Function and Pathophysiology
Biosimilars and Bioanalytical Methods
Publication details
- Journal / source
- Investigational New Drugs
- Publisher
- Springer Science and Business Media LLC
- Volume
- 44
- Issue
- 1
- Pages
- 1–8
- Publication date
- 9 January 2026
- Language
- EN